Consumers increasingly turn to 'Net for Web info: study

Share this article:
Elkin: pharma marketers should consider search.
Elkin: pharma marketers should consider search.

US consumers are turning to the Internet, even more so than their doctors, to research health information, according to a report from digital marketing company iCrossing.

According to the analysis, 59% of a group of 1,084 men and women aged 18 and older surveyed said they used the Internet as a resource for health and wellness-related information, while just 55% said they consulted with their physicians when they had a question.

The report, titled How America Searches: Health and Wellness, was conducted by The Opinion Research Corporation, an infoUSA research and consulting firm, for iCrossing in December.

Although consumers prefer the Net over physicians for research, docs are still the most trusted source of health info, the survey found.

When asked to identify the top three sources they trusted the most, 77% of consumers cited their primary care physicians, 55% their specialist physicians, and 37% their nurses or nurse practitioners. Only 24% listed the Internet as a top trusted source.

“Pharma marketers ought to consider channels that they hadn't before – most particularly search engines,” added iCrossing VP of strategy Noah Elkin told MM&M.

According to Elkin general search engines dominate consumer research.

The iCrossing survey found that two-thirds of online adults have used general search engines such as Google, Yahoo! and MSN to find health related info. Meanwhile, usage of health-specific search engines such as Healia, Medstory and Healthline were minimal by comparison.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...